The TOSCA.IT trial: a study designed to evaluate the effect of pioglitazone versus sulfonylureas on cardiovascular disease in type 2 diabetes. [electronic resource]
Producer: 20130503Description: e82 p. digitalISSN:- 1935-5548
No physical items for this record
Publication Type: Letter; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.